Exact Mass: 345.0974

Exact Mass Matches: 345.0974

Found 49 metabolites which its exact mass value is equals to given mass value 345.0974, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Capensinidin

Capensinidin

C18H17O7+ (345.0974)


An anthocyanidin cation consisting of benzopyrylium with hydroxy substituents at positions 3 and 7, a methoxy group at position 5 and a 4-hydroxy-3,5-dimethoxyphenyl group at position 2 respectively.

   

Hirsutidin

Hirsutidin

C18H17O7+ (345.0974)


An anthocyanidin cation consisting of benzopyrylium with hydroxy substituents at positions 3 and 5, a methoxy group at position 7 and a 4-hydroxy-3,5-dimethoxyphenyl group at position 2.

   

desulfosinalbin

Desulfo-p-hydroxybenzylglucosinolate

C14H19NO7S (345.0882)


   

Aquex

4-Chloro-N-(2,6-dimethylpiperidin-1-yl)-3-sulphamoylbenzene-1-carboximidic acid

C14H20ClN3O3S (345.0914)


   

4-[2-(3,4-Dihydro-6,7-dimethoxy-4-methyl-3-oxo-2-quinoxalinyl)ethyl]-3H-1,2,4-triazole-3,5(4H)-dione

4-[2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)ethyl]-4,5-dihydro-3H-1,2,4-triazole-3,5-dione

C15H15N5O5 (345.1073)


   

Vonoprazan

1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine

C17H16FN3O2S (345.0947)


A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor

   

Hirsutidin

3,5-Dihydroxy-2- (4-hydroxy-3,5-dimethoxyphenyl) -7-methoxy-1-benzopyrylium

C18H17O7 (345.0974)


   

Capensinidin

3,7,4-Trihydroxy-5,3,5-trimethoxyflavylium

C18H17O7 (345.0974)


   
   
   

Conicaquinone A

Conicaquinone A

C18H19NO4S (345.1035)


   
   
   

clopamide

clopamide

C14H20ClN3O3S (345.0914)


C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

4-Pyridoxic acid O-hexoside

4-Pyridoxic acid O-hexoside

C14H19NO9 (345.106)


   

benzoxazolium, 2-methyl-5-phenyl-3-(4-sulfobutyl)-,hydroxide, inner salt

benzoxazolium, 2-methyl-5-phenyl-3-(4-sulfobutyl)-,hydroxide, inner salt

C18H19NO4S (345.1035)


   

5-O-benzyl 2-O-ethyl 6,7-dihydro-4H-thieno[3,2-c]pyridine-2,5-dicarboxylate

5-O-benzyl 2-O-ethyl 6,7-dihydro-4H-thieno[3,2-c]pyridine-2,5-dicarboxylate

C18H19NO4S (345.1035)


   
   

1-hydroxy-4-[(4-methoxyphenyl)amino]anthraquinone

1-hydroxy-4-[(4-methoxyphenyl)amino]anthraquinone

C21H15NO4 (345.1001)


   

2-CHLORO-3-FORMYL-4-IODOPYRIDINE

2-CHLORO-3-FORMYL-4-IODOPYRIDINE

C18H19NO4S (345.1035)


   

1-(TERT-BUTOXYCARBONYL)-5-(TRIFLUOROMETHOXY)INDOLE-2-BORONIC ACID

1-(TERT-BUTOXYCARBONYL)-5-(TRIFLUOROMETHOXY)INDOLE-2-BORONIC ACID

C14H15BF3NO5 (345.0995)


   

[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-(trifluoromethoxy)indol-2-yl]boronic acid

[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-(trifluoromethoxy)indol-2-yl]boronic acid

C14H15BF3NO5 (345.0995)


   

4-Methoxy-2-naphthylamine p-toluenesulfonate salt

4-Methoxy-2-naphthylamine p-toluenesulfonate salt

C18H19NO4S (345.1035)


   

4-methylsulfanyl-2,7-diphenyl-8H-pyrido[2,3-d]pyrimidin-5-one

4-methylsulfanyl-2,7-diphenyl-8H-pyrido[2,3-d]pyrimidin-5-one

C20H15N3OS (345.0936)


   

4-PHENYL-1-(PHENYLSULFONYL)PIPERIDINE-4-CARBOXYLIC ACID

4-PHENYL-1-(PHENYLSULFONYL)PIPERIDINE-4-CARBOXYLIC ACID

C18H19NO4S (345.1035)


   

benzene-1,2,4-tricarboxylic acid,3-(2-methylimidazol-1-yl)propanenitrile

benzene-1,2,4-tricarboxylic acid,3-(2-methylimidazol-1-yl)propanenitrile

C16H15N3O6 (345.0961)


   

Vonoprazan Impurity 2

Vonoprazan Impurity 2

C17H16FN3O2S (345.0947)


   

N-[[3-Fluoro-4-ethoxy-pyrid-2-YL]ethyl]-N-[5-nitrilomethyl-pyridyl]-thiourea

N-[[3-Fluoro-4-ethoxy-pyrid-2-YL]ethyl]-N-[5-nitrilomethyl-pyridyl]-thiourea

C16H16FN5OS (345.106)


   

N-Hydroxy 1N(4-methoxyphenyl)sulfonyl-4-(Z,E-N-methoxyimino)pyrrolidine-2R-carboxamide

N-Hydroxy 1N(4-methoxyphenyl)sulfonyl-4-(Z,E-N-methoxyimino)pyrrolidine-2R-carboxamide

C13H19N3O6S (345.0995)


   

D-Para-Chlorophenyl-1-Acteamidoboronic Acid Alanine

D-Para-Chlorophenyl-1-Acteamidoboronic Acid Alanine

C13H19BClN2O6- (345.1025)


   

[(1R)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron

[(1R)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron

C13H19BClN2O6- (345.1025)


   

Chromophore (glu-tyr-gly)

Chromophore (glu-tyr-gly)

C16H15N3O6 (345.0961)


   

Vonoprazan

Vonoprazan

C17H16FN3O2S (345.0947)


A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor

   

2-[(2-Acetyl-5-tert-butylthiophen-3-yl)carbamoyl]benzoic acid

2-[(2-Acetyl-5-tert-butylthiophen-3-yl)carbamoyl]benzoic acid

C18H19NO4S (345.1035)


   

(4R)-2-acetyl-4-(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)-4-methyl-3-oxocyclohexa-1,5-dien-1-olate

(4R)-2-acetyl-4-(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)-4-methyl-3-oxocyclohexa-1,5-dien-1-olate

C18H17O7- (345.0974)


   

2-(2,3-Dimethoxyphenyl)-3-(4-methoxyphenyl)-4-thiazolidinone

2-(2,3-Dimethoxyphenyl)-3-(4-methoxyphenyl)-4-thiazolidinone

C18H19NO4S (345.1035)


   

N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide

N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide

C17H16ClN3O3 (345.088)


   

1-[1-(3-Fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanone

1-[1-(3-Fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanone

C16H16FN5OS (345.106)


   

4-O-demethylbarbatate

4-O-demethylbarbatate

C18H17O7- (345.0974)


   

(5E)-2-phenylimino-5-[(1-phenylpyrrol-2-yl)methylidene]-1,3-thiazolidin-4-one

(5E)-2-phenylimino-5-[(1-phenylpyrrol-2-yl)methylidene]-1,3-thiazolidin-4-one

C20H15N3OS (345.0936)


   

p-Hydroxybenzyldesulphoglucosinolate

p-Hydroxybenzyldesulphoglucosinolate

C14H19NO7S (345.0882)


   
   

CGP 25454A

CGP 25454A

C15H21Cl2N3O2 (345.1011)


CGP 25454A is a selective presynaptic dopamine autoreceptor antagonist which induces the increase of dopamine and acetyl choline. CGP 25454A can be used for major depression research[1].

   

PF-06685249

PF-06685249

C17H16ClN3O3 (345.088)


PF-06685249 (PF-249) is a potent and orally active allosteric AMPK activator with an EC50 of 12 nM for recombinant AMPK α1β1γ1. PF-06685249 can be used for diabetic nephropathy research[1].

   

Zacopride (hydrochloride)

Zacopride (hydrochloride)

C15H21Cl2N3O2 (345.1011)


Zacopride hydrochloride is a highly potent 5-HT3 receptor antagonist with Kis of 0.38 and 373 nM for 5-HT3 and 5-HT4 receptor, respectively. Zacopride hydrochloride is also a moderate IK1 channel agonist. Zacopride hydrochloride exerts significant antiarrhythmic and cardiac protective effects[1][2][3].

   

[3,5-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromen-7-ylidene](methyl)oxidanium

[3,5-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromen-7-ylidene](methyl)oxidanium

[C18H17O7]+ (345.0974)


   

7-(4-methylpent-3-en-1-yl)-2h,3h,4h-1λ⁶-naphtho[2,3-b][1,4]thiazine-1,1,5,10-tetrone

7-(4-methylpent-3-en-1-yl)-2h,3h,4h-1λ⁶-naphtho[2,3-b][1,4]thiazine-1,1,5,10-tetrone

C18H19NO4S (345.1035)


   

8-(4-methylpent-3-en-1-yl)-2h,3h,4h-1λ⁶-naphtho[2,3-b][1,4]thiazine-1,1,5,10-tetrone

8-(4-methylpent-3-en-1-yl)-2h,3h,4h-1λ⁶-naphtho[2,3-b][1,4]thiazine-1,1,5,10-tetrone

C18H19NO4S (345.1035)